Beneficial Effect of a Novel Diuretic, M17055, on Blood Pressure and Cardiovascular Hypertrophy in Spontaneously Hypertensive Rats.
スポンサーリンク
概要
- 論文の詳細を見る
We investigated the effects of a novel diuretic, M17055, on blood pressure and cardiovascular hypertrophy in spontaneously hypertensive rats (SHR). M17055 was orally administered once a day for 24 consecutive days to 14-week-old male SHR. M17055 at doses of 1.25, 2.5 and 5 mg/kg/day exerted a dose-related diuretic and antihypertensive effect during the treatment. The weight of the left ventricle normalized by body weight on the following day of the last dosage was significantly (P<0.01) reduced by M17055 at doses of 2.5 and 5 mg/kg/day in a dose-dependent manner. The effect of M17055 on cardiac hypertrophy was more potent (P<0.01) than that of captopril, when the comparison was performed at the doses of M17055 and captopril inducing the same extent of blood-pressure decrement. Vascular hypertrophy was evaluated by the media/lumen ratio (M/L) in the thoracic aorta and the first branch of the superior mesenteric artery. In the aorta, M/L was slightly, but not significantly, decreased by M17055 at doses of 2.5 and 5 mg/kg/day, whereas it was decreased significantly (P<0.01) by captopril. In the mesenteric artery, the ratio was significantly (P<0.05) reduced by M17055 at a dose of 5 mg/kg/day. These results suggest that M17055 possesses beneficial properties for the clinical treatment of hypertension.
- 公益社団法人 日本薬理学会の論文
著者
-
Mizota Masahiro
Fuji Central Research Laboratory Mochida Pharmaceutical Co. Ltd. 722
-
Uemura Akio
Fuji Central Research Laboratory, Mochida Pharmaceutical Co., Ltd.
-
Yamasaki Fumiaki
Fuji Central Research Laboratory, Mochida Pharmaceutical Co., Ltd.
-
Shinkawa Tomoaki
Fuji Central Research Laboratory, Mochida Pharmaceutical Co., Ltd.
-
Kato Yutaka
Fuji Central Research Laboratory, Mochida Pharmaceutical Co., Ltd.
-
Tsuchiya Naoko
Fuji Central Research Laboratory, Mochida Pharmaceutical Co., Ltd.
関連論文
- PHARMACOKINETIC STUDY OF ULINASTATIN AFTER INTRA-ARTICULAR ADMINISTRATION TO RABBITS
- Hypolipidemic Effect of Ethyl all-cis-5, 8, 11, 14, 17-Icosapentaenoate (EPA-E) in Rats
- Anti-Hypotensive Effects of M6434, an Orally Active .ALPHA.1-Adrenoceptor Agonist, in Rats.
- Beneficial Effect of a Novel Diuretic, M17055, on Blood Pressure and Cardiovascular Hypertrophy in Spontaneously Hypertensive Rats.